Literature DB >> 19025339

Increased differentiation of dermal mast cells in mice lacking the Mpl gene.

Barbara Ghinassi1, Maria Zingariello, Fabrizio Martelli, Rodolfo Lorenzini, Alessandro M Vannucchi, Rosa Alba Rana, Mitsuo Nishikawa, Giovanni Migliaccio, John Mascarenhas, Anna Rita Migliaccio.   

Abstract

Thrombopoietin interactions with its receptor, Mpl, play an important role in the regulation of hematopoietic stem/progenitor cell proliferation and differentiation. In this study, we report that the mast cell restricted progenitor cells (MCP) and the mast cell precursors in the bone marrow of wild-type mice express Mpl on their surface. Furthermore, targeted deletion of the Mpl gene in mice decreases the number of MCP while increasing the number of mast cell precursors present in the marrow and spleen. It also increases the number of mast cells present in the dermis, in the peritoneal cavity, and in the gut of the mice. In addition, serosal mast cells from Mpl(null) mice have a distinctive differentiation profile similar to that expressed by wild-type dermal mast cells. These results suggest that not only does ligation of thrombopoietin with the Mpl receptor exert an effect at the mast cell restricted progenitor cell level, but also plays an unexpected yet important role in mast cell maturation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19025339      PMCID: PMC3135224          DOI: 10.1089/scd.2008.0323

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  58 in total

1.  The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor.

Authors:  Barbara Ghinassi; Massimo Sanchez; Fabrizio Martelli; Giovanni Amabile; Alessandro Maria Vannucchi; Giovanni Migliaccio; Stuart H Orkin; Anna Rita Migliaccio
Journal:  Blood       Date:  2006-10-12       Impact factor: 22.113

Review 2.  Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis.

Authors:  Stephen J Galli; Mindy Tsai
Journal:  J Dermatol Sci       Date:  2007-11-19       Impact factor: 4.563

Review 3.  Role of thrombopoietin in mast cell differentiation.

Authors:  Anna Rita Migliaccio; Rosa Alba Rana; Alessandro M Vannucchi; Francesco A Manzoli
Journal:  Ann N Y Acad Sci       Date:  2007-04-27       Impact factor: 5.691

Review 4.  Mast cell-committed progenitors.

Authors:  Yukihiko Kitamura; Akihiko Ito
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-01       Impact factor: 11.205

Review 5.  Mast cell proteases.

Authors:  Gunnar Pejler; Magnus Abrink; Maria Ringvall; Sara Wernersson
Journal:  Adv Immunol       Date:  2007       Impact factor: 3.543

6.  Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor.

Authors:  Jian C Qi; Jing Wang; Sravan Mandadi; Kumiko Tanaka; Basil D Roufogalis; Michele C Madigan; Kenneth Lai; Feng Yan; Beng H Chong; Richard L Stevens; Steven A Krilis
Journal:  Blood       Date:  2005-09-06       Impact factor: 22.113

7.  Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis.

Authors:  Yojiro Arinobu; Hiromi Iwasaki; Michael F Gurish; Shin-ichi Mizuno; Hirokazu Shigematsu; Hidetoshi Ozawa; Daniel G Tenen; K Frank Austen; Koichi Akashi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

8.  Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems.

Authors:  S Finotto; Y A Mekori; D D Metcalfe
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

9.  Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease.

Authors:  Anna Rita Migliaccio; Fabrizio Martelli; Maria Verrucci; Giovanni Migliaccio; Alessandro Maria Vannucchi; Hongyu Ni; Mingjiang Xu; Yi Jiang; Betty Nakamoto; Thalia Papayannopoulou; Ronald Hoffman
Journal:  Exp Hematol       Date:  2008-02       Impact factor: 3.084

10.  Differentiation and maintenance of mast cells from CD34(+) human cord blood cells.

Authors:  Takashi Yoshikubo; Tomoaki Inoue; Mizuho Noguchi; Hisafumi Okabe
Journal:  Exp Hematol       Date:  2006-03       Impact factor: 3.084

View more
  3 in total

Review 1.  Mast cell progenitor trafficking and maturation.

Authors:  Jenny Hallgren; Michael F Gurish
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

2.  Gene therapy of MPL deficiency: challenging balance between leukemia and pancytopenia.

Authors:  Daniel C Wicke; Johann Meyer; Guntram Buesche; Dirk Heckl; Hans Kreipe; Zhixiong Li; Karl H Welte; Matthias Ballmaier; Christopher Baum; Ute Modlich
Journal:  Mol Ther       Date:  2009-10-20       Impact factor: 11.454

3.  The thrombopoietin/MPL axis is activated in the Gata1low mouse model of myelofibrosis and is associated with a defective RPS14 signature.

Authors:  M Zingariello; L Sancillo; F Martelli; F Ciaffoni; M Marra; L Varricchio; R A Rana; C Zhao; J D Crispino; A R Migliaccio
Journal:  Blood Cancer J       Date:  2017-06-16       Impact factor: 11.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.